Due to the PD‐L2 binds to PD‐1 with stronger affinity than PD‐L1,27 probably during acute COVID‐19, the immune suppression is mediated mainly by PD‐L1 in COVID‐ILD patients, and it does not happen during post‐COVID‐19. Here, PDCD1LG2 is linked to COVID-19.